Location History:
- Gaithersburg, MD (US) (2001)
- North Potomac, MD (US) (2001)
Company Filing History:
Years Active: 2001
Title: The Innovations of Attila Lőrincz
Introduction
Attila Lőrincz is a notable inventor based in Gaithersburg, MD, who has made significant contributions to the field of genetic testing and viral detection. With a total of two patents to his name, Lőrincz has developed innovative solutions that enhance the accuracy and efficiency of medical diagnostics.
Latest Patents
Lőrincz's latest patents include a non-radioactive hybridization assay and kit designed for the detection of genetic defects, microbial infections, and viral infections, such as human papillomavirus. This assay involves treating a test sample with a base and incubating it with nucleic acid probes specific for target nucleic acids. The hybrids formed are captured onto a solid phase coated with an anti-hybrid antibody, allowing for the elimination of unhybridized probes and the detection of the bound hybrids. Another significant patent focuses on an improved assay for detecting hepatitis B virus. This improvement involves concentrating viral particles from a biological sample through centrifugation, enabling the manipulation or detection of nucleic acid molecules within the viral particles using various suitable procedures.
Career Highlights
Attila Lőrincz is currently associated with Digene Corporation, where he continues to work on advancing diagnostic technologies. His expertise in the field has led to the development of groundbreaking assays that are crucial for public health.
Collaborations
Lőrincz has collaborated with notable colleagues, including Chaka Impraim and Sharon Challberg, contributing to a dynamic research environment that fosters innovation.
Conclusion
Attila Lőrincz's work exemplifies the impact of innovative thinking in the medical diagnostics field. His patents reflect a commitment to improving health outcomes through advanced technology.